Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors

Author(s):  
Fatma Babikr ◽  
Jiangbo Wan ◽  
Aizhang Xu ◽  
Zhaojia Wu ◽  
Shahid Ahmed ◽  
...  
2018 ◽  
Author(s):  
G Min ◽  
HS Choi ◽  
W Kim ◽  
SJ Choi ◽  
JM Lee ◽  
...  

2000 ◽  
Vol 65 (11) ◽  
pp. 1820-1832
Author(s):  
Miloslav Pekař ◽  
Pavel Kopecký

Rheokinetics of polybutadiene-based polyurethanes was studied. Sixteen mixtures differing in the miscibility of reactive components and hard segments contents were prepared. Regardless of the miscibility of the components, the rheokinetics behaviour is qualitatively very similar. The viscous response part is formed and finished much earlier than the elastic part. The quantitative dissimilarities, caused by cooperative effect of miscibility and differences in reactivity, are described. Using a well miscible initial mixture need not give the best results as a reactive crosslinker can easily react with isocyanate and separate from the rest of the reaction mixture thus impairing the final phase structure.


2021 ◽  
Vol 10 (1) ◽  
pp. 1875638
Author(s):  
Jia Yang ◽  
Aydin Eresen ◽  
Junjie Shangguan ◽  
Quanhong Ma ◽  
Vahid Yaghmai ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 2862
Author(s):  
Rasmus V. Flak ◽  
Rune V. Fisker ◽  
Niels H. Bruun ◽  
Mogens T. Stender ◽  
Ole Thorlacius-Ussing ◽  
...  

(1) Background: Irreversible electroporation (IRE) is a nonthermal ablation technique that is being studied in nonmetastatic pancreatic cancer (PC). Most published studies use imaging outcomes as an efficacy endpoint, but imaging interpretation can be difficult and has yet to be correlated with survival. The aim of this study was to examine the correlation of imaging endpoints with survival in a cohort of IRE-treated PC patients. (2) Methods: Several imaging endpoints were examined before and after IRE on 18F-fluorodeoxyglucose positron emission tomography (PET) with computed tomography. Separate analyses were performed at the patient and lesion levels. Mortality rate (MR) ratios for imaging endpoints after IRE were estimated. (3) Results: Forty-one patients were included. Patient-level analysis revealed that progressive disease (PD), as defined by RECIST 1.1, is correlated with a higher MR at all time intervals, but PD, as defined by EORTC PET response criteria, is only correlated with the MR in the longest interval. No correlation was found between PD, as defined by RECIST, and the MR in the lesion-level analysis. (4) Conclusions: Patient-level PD, as defined by RECIST, was correlated with poorer survival after IRE ablation, whereas no correlations were observed in the lesion-level analyses. Several promising lesion-level outcomes were identified.


2021 ◽  
Vol 10 (8) ◽  
pp. 1609
Author(s):  
Zainab L. Rai ◽  
Roger Feakins ◽  
Laura J. Pallett ◽  
Derek Manas ◽  
Brian R. Davidson

Locally advanced pancreatic cancer (LAPC) accounts for 30% of patients with pancreatic cancer. Irreversible electroporation (IRE) is a novel cancer treatment that may improve survival and quality of life in LAPC. This narrative review will provide a perspective on the clinical experience of pancreas IRE therapy, explore the evidence for the mode of action, assess treatment complications, and propose strategies for augmenting IRE response. A systematic search was performed using PubMed regarding the clinical use and safety profile of IRE on pancreatic cancer, post-IRE sequential histological changes, associated immune response, and synergistic therapies. Animal data demonstrate that IRE induces both apoptosis and necrosis followed by fibrosis. Major complications may result from IRE; procedure related mortality is up to 2%, with an average morbidity as high as 36%. Nevertheless, prospective and retrospective studies suggest that IRE treatment may increase median overall survival of LAPC to as much as 30 months and provide preliminary data justifying the well-designed trials currently underway, comparing IRE to the standard of care treatment. The mechanism of action of IRE remains unknown, and there is a lack of data on treatment variables and efficiency in humans. There is emerging data suggesting that IRE can be augmented with synergistic therapies such as immunotherapy.


Sign in / Sign up

Export Citation Format

Share Document